PATENT CLAIM ANALYSIS

Application Number: 15950889
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-01
Patent Classification: ["435", "006100"]

Abstract:
Disclosed are methods for detecting the presence of a carcinoma or an increased likelihood that a carcinoma is present in a subject. More particularly, the present invention discloses methods for diagnosis, screening, treatment and monitoring of carcinomas associated with aberrant DNA methylation of the MED15 promoter region.

Claim (Index 55):
A composition according to  claim 47 , further comprising probes and primers specific for one or more CpG sites in the promoters of one or more gene selected from the group comprising RASSF1\u03b1, TIMP3, DAPK1 and P16 INK4\u03b1 .

Metadata:
- Claim Count in Document: 23.0
- Percentile: 91.0
- Lexical Diversity: 1.33333
- Patent Class: 435.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['10955340', '12231337', '13634321', '15032638', '13224024']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6198261844812767
- 35 USC 102 Novelty (BERT): 0.5102070248818386
- Combined Prediction Score: 0.6088642685213328
- Mean Citation Score: 299.196558
- Max Citation Score: 312.9905
- Similarity Product: 249.051078450501

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test